Northern Trust Portfolio holdings
AUM
$727B
1-Year Return
23.08%
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
This Quarter Return
-2.61%
1 Year Return
+23.08%
3 Year Return
+97.56%
5 Year Return
+177.34%
10 Year Return
+414.74%
AUM
$516B
AUM Growth
-$4.12B
(-0.79%)
Cap. Flow
+$14.8B
Cap. Flow
% of AUM
2.86%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
4,620
New
87
Increased
2,316
Reduced
1,713
Closed
158
Top Buys
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$743M |
| 3 |
Amazon
AMZN
|
+$414M |
| 4 |
NVIDIA
NVDA
|
+$396M |
| 5 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$322M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$416M |
| 2 |
Johnson & Johnson
JNJ
|
+$128M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$128M |
| 4 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$75.9M |
| 5 |
WWE
World Wrestling Entertainment
WWE
|
+$68.2M |
Sector Composition
| 1 | Technology | 24.83% |
| 2 | Healthcare | 12.27% |
| 3 | Financials | 11.08% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Pyxis Oncology
PYXS
$116M
| $105K | ﹤0.01% |
52,746
+5,353
| +11% | +$10.7K |
|
4002
Personalis
PSNL
$478M
| $105K | ﹤0.01% |
86,591
-2,886
| -3% | -$3.49K |
|
4003
Arena Group
AREN
$291M
| $105K | ﹤0.01% |
24,418
| – | – |
|
|
SYRS
4004
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $104K | ﹤0.01% |
26,394
+5,667
| +27% | +$22.4K |
|
4005
Flotek Industries
FTK
$331M
| $104K | ﹤0.01% |
23,418
+4,086
| +21% | +$18.1K |
|
4006
Shattuck Labs
STTK
$83.8M
| $103K | ﹤0.01% |
68,066
-2,152
| -3% | -$3.27K |
|
|
IRD
4007
Opus Genetics, Inc. Common Stock
IRD
$79.7M
| $103K | ﹤0.01% |
30,870
-297
| -1% | -$995 |
|
4008
United States Natural Gas Fund
UNG
$597M
| $102K | ﹤0.01% |
3,750
| – | – |
|
4009
ProPhase Labs
PRPH
$20.4M
| $102K | ﹤0.01% |
23,424
-191
| -0.8% | -$835 |
|
4010
Heartbeam
BEAT
$47M
| $102K | ﹤0.01% |
47,325
| – | – |
|
4011
Broadwind
BWEN
$50M
| $102K | ﹤0.01% |
31,730
-287
| -0.9% | -$918 |
|
4012
Great Elm Group
GEG
$82.6M
| $101K | ﹤0.01% |
47,112
| – | – |
|
4013
Aquestive Therapeutics
AQST
$590M
| $100K | ﹤0.01% |
65,500
| – | – |
|
4014
Comscore
SCOR
$31.6M
| $99.9K | ﹤0.01% |
8,138
-871
| -10% | -$10.7K |
|
4015
Cardiff Oncology
CRDF
$136M
| $99.2K | ﹤0.01% |
71,386
-1,000
| -1% | -$1.39K |
|
4016
IRIDEX
IRIX
$22.5M
| $99.1K | ﹤0.01% |
39,013
-684
| -2% | -$1.74K |
|
4017
Perma-Pipe International
PPIH
$261M
| $98.4K | ﹤0.01% |
12,038
-2,006
| -14% | -$16.4K |
|
4018
CEL-SCI Corp
CVM
$66.6M
| $97.8K | ﹤0.01% |
2,608
| – | – |
|
4019
Ideal Power
IPWR
$42.9M
| $97.3K | ﹤0.01% |
10,038
-93
| -0.9% | -$902 |
|
|
TUP
4020
DELISTED
Tupperware Brands Corporation
TUP
| $97.2K | ﹤0.01% |
69,442
-5,467
| -7% | -$7.65K |
|
|
CYT
4021
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $97.1K | ﹤0.01% |
34,189
+15,205
| +80% | +$43.2K |
|
4022
Annovis Bio
ANVS
$45M
| $96.6K | ﹤0.01% |
10,180
| – | – |
|
4023
Assembly Biosciences
ASMB
$171M
| $95.7K | ﹤0.01% |
9,010
| – | – |
|
|
DMTK
4024
DELISTED
DermTech, Inc. Common Stock
DMTK
| $95.2K | ﹤0.01% |
66,100
-64
| -0.1% | -$92 |
|
4025
Corvus Pharmaceuticals
CRVS
$442M
| $94.9K | ﹤0.01% |
65,017
| – | – |
|